Harpoon to present updated interim results from the Phase 1/2 clinical trial of T Cell engager #HPN328 at American Society of Clinical Oncology (ASCO) - Genitourinary Cancers View full release here: https://lnkd.in/esvmmXBk #immunooncology #TCell #cancer #biotech #ASCOGU2024
